# DiaMedica Therapeutics Inc.: Form DEF 14A, filed Apr 4, 2023

- Company: [DiaMedica Therapeutics Inc.](/companies/dmac.md) (CIK 1401040)
- Form: DEF 14A
- Filed: 2023-04-04
- Accepted by EDGAR: Apr 4, 2023, 07:02 ET
- Period: 2023-05-17
- Accession: 0001437749-23-009169
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1401040/000143774923009169/dmtp20230328_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1401040/000143774923009169/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1401040/000143774923009169/dmtp20230328_def14a.htm

Filed Apr 4, 2023.
Source: SEC EDGAR, the filing index for accession 0001437749-23-009169. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.